Infinity Pharmaceuticals logo Infinity Pharmaceuticals Inc. (NASDAQ:INFI) major shareholder Value Fund L. P. Biotechnology bought 1,510,000 shares of the business’s stock in a transaction dated Tuesday, April 10th. The shares were bought at an average cost of $1.97 per share, for a total transaction …
06
May
Leave a Reply
You must be logged in to post a comment.